Cargando…
Clinical data for intravenous iron – debunking the hype around hypersensitivity
BACKGROUND: Reluctance to use intravenous (IV) iron for the treatment of iron deficiency continues due to a perceived high risk of severe hypersensitivity reactions (HSRs). Additionally, it has been hypothesized that ‘dextran‐derived’ IV iron products (e.g., ferumoxytol [FER] and ferric derisomaltos...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384172/ https://www.ncbi.nlm.nih.gov/pubmed/32479668 http://dx.doi.org/10.1111/trf.15837 |